FTAI Aviation Ltd vs Tenet Healthcare Corporation — how do they compare? FTAI Aviation Ltd trades at $171 (market cap $17.96B), while Tenet Healthcare Corporation trades at $260 (market cap $20.92B). The key difference: Tenet Healthcare Corporation is the larger of the two by market cap, and FTAI Aviation Ltd pays a 1.14% dividend while Tenet Healthcare Corporation pays none. Which is the better fit depends on your goals — on Pluang, investors hold FTAI Aviation Ltd for 22 Days and Tenet Healthcare Corporation for 15 Days on average.
| FTAI | THC | |
|---|---|---|
Market Cap | $17.96B | $20.92B |
Volume | 1,695,650 | 455,764 |
Sector | Industrials | Health |
52-Week High | $310.04 | $280.77 |
52-Week Low | $152.80 | $161.37 |
Typical Hold Time | 22 Days | 15 Days |
Enterprise Value | $21.07B | $32.00B |
Dividend Yield | 1.14% | — |
Signals from Pluang's Aura AI — not financial advice
FTAI Aviation trades at $174.83, down 2.57% today, with a bearish technical signal. The company reported strong revenue growth to $2.51B in 2025 but missed EPS estimates for three consecutive quarters. Recent developments include a $500 million share repurchase program and a strategic acquisition of 27 Boeing aircraft, signaling aggressive expansion. Analyst consensus remains unanimously bullish with a $321.25 price target, despite negative operating cash flow and declining net income margins.
The outlook is mixed: robust institutional support and growth initiatives contrast with earnings misses and cash flow concerns. Key risks include execution of new ventures and sensitivity to aviation sector cycles. The stock offers significant upside if operational improvements materialize, but investors face volatility from quarterly performance gaps and macroeconomic pressures on the industry.
Tenet Healthcare (THC) trades at $259.83, up 0.53% with strong technical momentum and bullish moving average signals. The company demonstrates robust fundamentals with consistent earnings beats (Q4 2025-Q2 2026), 82.83% gross margins, and 53.31% ROE. Recent news highlights strong cash flow supporting capital returns, with Q3 2026 results expected October 29, 2026.
THC presents compelling value with a 10.04 P/E ratio and 81.25% analyst buy ratings. Upside potential to $283.36 consensus target exists, though negative cash flow trends and insider selling warrant monitoring. The stock's premium valuation (P/B 4.49) requires sustained execution amid healthcare sector volatility.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
FTAI Aviation owns and maintains a fleet of commercial aircraft and engines. It focuses on the specialized maintenance of the CFM56 engine, helping airlines reduce costs through efficient asset management.
Read more on FTAI →Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →